
The forum provides a focused, in-person platform for the exchange of ideas on membrane technologies and their industrial applications, bringing together professionals seeking insights on new technologies, research, trends, applications, and best practices.
For additional event information, visit the Membrane Technology Forum website.
GEA will showcase a comprehensive portfolio of cross-flow membrane filtration solutions featuring microfiltration, ultrafiltration, nanofiltration, and reverse osmosis — designed to meet diverse industry needs for efficient separation and concentration while maintaining the integrity of temperature-sensitive products.
Membrane filtration can support process performance and product quality across applications in food, dairy, beverage, chemical, biotechnology, fermentation, and starch/sweetener processing—where gentle, non-thermal separation or concentration is a benefit to the overall process design.
At the 2026 Membrane Technology Forum, GEA will place additional emphasis on:
Shanti Bhushan will present:
“Membrane Purification Enables Clean Beauty Actives” (to be transmitted live through Encore).
Shanti Bhushan has over two decades of experience in research, development, scale-up and commercialization of membrane technologies across dairy, food, beverage, chemical, biotechnology, and pharmaceutical applications. He has been with GEA for more than 15 years. He earned his PhD from the University of Wisconsin–Madison in 2008 in Food Science, with a focus on fractionation of dairy proteins using charged and functionalized ultrafiltration membranes.
Stop by tabletop/exhibit space #22 to discuss how membrane filtration can help address your process objectives - whether your focus is separation, concentration, purification, yield improvement, or resource efficiency.
GEA will also use this opportunity to highlight our GEA New Food Application & Technology Center (ATC) in Janesville, Wisconsin, which is dedicated to supporting alternative proteins and sustainable food solutions - including pathways to develop commercially viable processes for producing alternative proteins and related applications.
The ATC supports customers as they conceive, develop, and test processes across a range of alternative protein approaches, helping generate data and representative samples that can accelerate scale-up and commercialization.